Effect of the Motilin Receptor Agonist, Erythromycin, on Hunger and Food Intake; Study of Role of Cholinergic Pathways
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
In this study, the investigators will evaluate if the food intake associated with the
infusion of erythromycin is caused by the phase 3 contractions or by another yet unknown
effect of erythromycin. To obtain this the investigators will use atropine, a muscarinic
receptor antagonist, to inhibit the formation of contractions induced by a low dose of
erythromycin